Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Design Pharmaceuticals
AddedFeb 16, 2024
UpdatedJun 18, 2026
Design Pharmaceuticals

Design Pharmaceuticals

Seed

Design Pharma: Proprietary tech enabling drug discovery and biosynthetic production.

HQ
Cambridge, MA, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Design Pharmaceuticals, founded with a mission to revolutionize drug discovery, focuses on leveraging proprietary ultra-high throughput bioscience technologies. The company aims to dramatically accelerate the discovery and biosynthetic production of drug candidates, particularly targeting G-protein-coupled receptors (GPCRs). By unlocking and deorphanizing these drug targets, Design Pharmaceuticals seeks to develop new treatments for diseases lacking satisfactory therapies.

Notable affiliated individuals and investors include experts in bioscience and pharmaceutical industries, though specific names are not provided. Key achievements include the development of a unique suite of technologies that significantly outpace current industry capabilities in GPCR drug discovery. The overall impact of Design Pharmaceuticals lies in its potential to transform the landscape of drug discovery, offering hope for patients with unmet medical needs.

Design Pharmaceuticals - Similar Companies

Drug Design Methodologies logo

Drug Design Methodologies

newdrugdesign.com

Seven Biosciences logo

Seven Biosciences

ZielBio logo

ZielBio

zielbio.com

Photonic Pharma logo

Photonic Pharma

photonicpharma.com

Generian Pharmaceuticals logo

Generian Pharmaceuticals

generian.com

Alcinous Pharmaceuticals logo

Alcinous Pharmaceuticals

PathDrugomics logo

PathDrugomics

1200 Pharma logo

1200 Pharma

1200pharma.com

BioLeap logo

BioLeap

Deep Apple Therapeutics logo

Deep Apple Therapeutics

deepappletx.com

Redesign Science logo

Redesign Science

Pepper Bio logo

Pepper Bio

pepper.bio

Discovery Innovations logo

Discovery Innovations

Biosim logo

Biosim

Septerna logo

Septerna

septerna.com

Design Pharmaceuticals - Quick Facts

Who are Design Pharmaceuticals' competitors?

Companies similar to Design Pharmaceuticals include Drug Design Methodologies, Seven Biosciences, ZielBio and Photonic Pharma.

When was Design Pharmaceuticals founded?

Design Pharmaceuticals was founded in 2018.

Where is Design Pharmaceuticals' headquarters located?

Design Pharmaceuticals' headquarters is located in Cambridge, MA, US.

When was Design Pharmaceuticals' last funding round?

Design Pharmaceuticals' most recent funding round was for $5M (USD) in April 2022.

How much has Design Pharmaceuticals raised to-date?

As of Apr 12, 2022, Design Pharmaceuticals has raised a total of $5M (USD).

How many employees does Design Pharmaceuticals have?

Design Pharmaceuticals has 18 employees as of Feb 5, 2024.

Design Pharmaceuticals - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Drug Discovery
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified